× Business
TelecomHealthcareDigital MarketingERPRetailMedia and EntertainmentOil and GasFood and BeveragesMarketing and AdvertisingBanking and Insurance
Technology
Big DataCloudIT ServiceSoftwareMobileSecurityNetworkingStorageCyber SecuritySAPData AnalysisloTBio Tech
Platform
Cisco DATABASE Google IBM Juniper Microsoft M2M Oracle Red hat Saas SYMANTEC
Leadership
CEO ReviewCMO ReviewCFO ReviewCompany Review
Magazines
US INDIA ASIA ARCHIVE
Startups Opinion Yearbook Readers Speak Contact Us

BIO TECH 

FEATURED

The Biotech firm Oncolytics enters into an agreement with Adlai Nortye

The biotech company Oncolytics which focuses on developing Reolysin enters into an agreement with Adlai Nortye in developing new treatments for cancer and the metabolic diseases. Adlai Nortye is a sci...  Read More

siliconreview-oncolytics-and-adlai-nortye

TRENDING


NEWS

siliconreview-bacteria-can-now-be-used-to-make-natural-colors-from-simple-sugar

Bacteria can now be used to make natural colors from simple sugar

Researchers at Rensselaer Polytechnic Institute have shown that four strains of E. coli bacteria working together can convert sugar into the natural red anthocyanin pigment found i...   Read More

siliconreview-pharma-mammoth-merck-sharp-dohme-msd-and-german-noxxon-pharma-begin-testing-immunoncologic-combo

Pharma mammoth Merck Sharp & Dohme (MSD) and German Noxxon Pharma begin testing immunoncologic combo

In the December of 2016, Berlin based Noxxon Pharma AG made a deal with Merck & Co. /MSD to assess the synergistic potential of NOXA1/2 and pembrolizumab immune cancer therapy....   Read More


YOU MIGHT ALSO LIKE::

ENROLL FOR UPCOMING ISSUE